Profile: Kyowa Hakko Kirin Co Ltd (4151.T)
4151.T on Tokyo Stock Exchange
Price Change (% chg)
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities. The Others segment is involved in the logistics, contracting, retail and wholesale, and insurance agency businesses, as well as the manufacture and sale of industrial alcohol. As of December 31, 2012, it had 49 subsidiaries, 5 associated companies and one parent company.
Kyowa Hakko Kirin Co Ltd
5F, Ohtemachi Bldg., 1-6-1, Ote-
CHIYODA-KU TKY 100-8185